心理危机多维度护理干预和自我效能干预结合护理方案在晚期肝癌介入患者中的实施效果分析

探究晚期肝癌介入患者在护理期间,运用心理危机多维度护理干预与自我效能干预结合运用的效果。方法 2023.1-2024.1时间阶段中,将70名病人实施划分,将常规护理运用在对照组中,将心理危机多维度护理与自我效能联合运用在观察组中,数值汇总比对。结果 护理后,观察组自我护理能力提高,患者的负面情绪降低,同时患者的睡眠质量与生活质量提高,P<0.05。结论 晚期肝癌患者在实施护理期间,为其予以心理危机多维度护理与自我效能联合运用之后,可提高患者的自我护理能力,并且安抚患者的情绪,令患者的睡眠与生活质量逐步增强。

芬太尼透皮贴剂联合吗啡皮下注射在晚期肝癌介入术后疼痛护理中的应用

目的分析芬太尼透皮贴剂联合吗啡皮下注射在晚期肝癌介入术后疼痛护理的应用效果。方法 2015年12月—2018年6月,于海军军医大学附属长海医院收治的晚期肝癌患者中选取86例,所有患者均行介入术治疗,将患者随机分为两组,各43例。对照组患者在术后疼痛护理中单独应用吗啡皮下注射,观察组患者则在术后疼痛护理中采用芬太尼透皮贴剂联合吗啡皮下注射,比较两组患者术后镇痛情况与药物副作用发生情况。结果与对照组比较,观察组患者治疗后2 h、治疗后12 h、治疗后24 h的NRS评分更低,组间差异有统计学意义(P<0.05)。结论芬太尼透皮贴剂联合吗啡皮下注射在晚期肝癌介入术后疼痛护理的应用效果显著,值得推广。

时效性激励理论下护理干预对晚期肝癌介入患者的应用价值评估

观察时效性激励理论下护理干预对晚期肝癌介入患者的应用疗效。方法 我院2022年7月-2024年7月收治的76位晚期肝癌介入患者基于数字随机法均分为对照组(常规护理干预)与实验组(时效性激励理论下护理干预),各38位,比较两组患者护理效果。结果 实验组患者护理后心理情绪控制效果、癌症自我管理效能及护理满意度均优于对照组(P<0.05)。结论 晚期肝癌介入患者时效性激励理论下护理干预可缓解其负面情绪,引导其情绪趋近正向,提升患者自我管理效能及满意度。

Efficacy of transcatheter arterial chemoembolization combined with ganfule on advanced hepatocellular carcinoma

Objective： The aim of this study was to evaluate the efficacy of transcatheter arterial chemoembolization （TACE） combined with a Chinese compound preparation of ganfule on advanced hepatocellular carcinoma （HCC）. Methods： The study population consisted of 132 advanced HCC patients with Child-pugh NB. Tumor in all patients was involved with main trunk of portal vein and/or inferior vena cava, or local lymph node metastasis, or distant metastasis. TACE combined with ganfule were performed in 65 patients with advanced HCC （interventional treatment group）, 67 patients were treated with traditional Chinese herbal drug alone （Chinese herb group）. The prime end point was overall survival （OS）, and prognostic factors were analyzed. Results： The median OS was 205 days [95% confidence interval （CI）, 155-255 days] in interventional treatment group and 127 days （95% CI, 70-184 days） in Chinese herb group （P 〈 0.05）. The 6-month, 1-year, and 2-year OS rates were 58.9%, 29.1%, 7.7% in interventional treatment group, and 33.3%, 12.3%, 1.8% in Chinese herb group, respectively. The portal vein thrombosis, ECOG performance status （PS） were independent prognostic factors for OS. Conclusion： Ttranscatheter arterial chemoembolization combined with a Chinese compound preparation of ganfule could greatly prolong the OS of advanced HCC patients. The portal vein thrombosis and ECOG PS were independent prognostic factors for OS.

Interventional and synthetic therapy of advanced hepatocellular carcinoma

OBJECTIVE: To evaluate the clinical efficacy of interventional therapy in the treatment of hepatocellular carcinoma (HCC). METHODS: Thirty-three patients with HCC were synthetically treated by systematic measures. Among them, percutaneous port-catheter system (PCS) implantation via the femoral artery was performed in 21 cases. Patients with haemorrhage were treated with prothrombin complex concentrate and fibroraas, and patients with hepatic encephalopathy by branched-chain amino acids and arginine. RESULTS: All indwelling catheters of PCS were patent and no catheter tip dislocations were observed. Of 33 patients with advanced HCC, the mean survival rate was 20.1 months and 12 (36%) patients survived more than 2 years. CONCLUSION: Patients with advanced HCC were treated by synthetic measures. Survival was prolonged, quality of life was improved significantly, and the effectiveness of interventional therapy was further improved.